Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COUNTER-COVID: Oral imatinib to prevent pulmonary vascular leak in severe COVID-19
2020-001236-10Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Imatinib with Placebo (2 arms). Primary endpoint: Time to liberation from ventilation and supplemental oxygen. Started Mar 2020; status: completed.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001236-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001236-10.